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1. Introduction 
Cytochrome P450 enzymes (CYPs) are active in the metabolism of wide variety of 
xenobiotics. The investigation of the contributions of human CYPs in pesticides metabolism, 
especially insecticides, is still growing. One of the background tools to facilitate this task is 
by sorting the contribution of each human CYP isoform in the metabolism of pesticides. This 
paper attempts to provide a comprehensive literature survey on the role of human hepatic 
CYPs such as human CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, 
CYP2D6, CYP2E1, CYP3A4, CYP3A5 and CYP3A7 in pesticides biotransformation in vitro 
as well as to sort the reactions mediated. Based on relevant publications identified by 
searching databases from 1995 through 2011, more than 400 metabolic reactions were 
reported to be mediated at least in part by human CYPs in vitro. Some information on older 
papers was obtained from previous literature surveys compiled by Hodgson 2001 & 2003. 
Finally, we give brief insight into potential modulations and consequences of human CYP 
genes – pesticides interactions. 
2. Xenobiotic biotransformation 
Xenobiotic biotransformation is the process by which lipophilic foreign compounds are 
metabolized through enzymatic catalysis to hydrophilic metabolites that are eliminated 
directly or after conjugation with endogenous cofactors via renal or biliary excretion. These 
metabolic enzymes are divided into two groups, Phase I and Phase II enzymes (Rendic and 
Di Carlo, 1997; Oesch et al. 2000). Phase I reactions are mediated primarily by cytochrome 
P450 family of enzymes, but other enzymes (e.g. flavin monooxygenases, peroxidases, 
amine oxidases, dehydrogenases, xanthine oxidases) also catalyze oxidation of certain 
functional groups. In addition to the oxidative reactions there are different types of 
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hydrolytic reactions catalysed by enzymes like carboxylesterases and epoxide hydrolases 
(Low, 1998; Hodgson and Goldstein, 2001; Parkinson, 2001).  
 
CYP 1A 1























Fig. 1. The percentage of human recombinant cytochrome P450 isoforms involved in 
pesticides metabolism. 63 compounds (36 insecticides; 14 fungicides; 10 herbicides; 2 plant 
growth regulators and a biocide agent) were metabolized at least in part by one or more 
human enzymes yielded 495 metabolic reactions. 
Phase I products are not usually eliminated rapidly, but undergo a subsequent reaction in 
which an endogenous substrate such as glucuronic acid, sulfuric acid, acetic acid, or an 
amino acid combines with the existing or newly added or exposed functional group to form 
a highly polar conjugate to make them more easily excreted (LeBlanc and Dauterman, 2001; 
Rose and Hodgson, 2004; Zamek-Gliszczynski et al. 2006).  
 
 
Fig. 2. Schematic description of the two main phases of drug metabolism. In general, a 
parent compound is converted into an intermediate metabolite which is then conjugated, 
but metabolism may involve only one of these reactions. Some metabolites are more toxic 
than the parent compound (Ahokas and Pelkonen, 2007; Liska et al. 2006).  
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3. Cytochrome P450 enzyme system 
3.1 Nomenclature, location and microsomal preparation  
P450 enzymes are categorized into families and subfamilies by their sequence similarities. 
The human genomes comprise 57 CYP genes and about the same numbers of pseudogenes, 
which are grouped according to their sequence similarity into 18 families and 44 
subfamilies. The web site, http://drnelson.utmem.edu/CytochromeP450.html, contains 
more detailed classification related to the cytochrome P450 metabolizing enzymes. The CYP 
enzymes in the families 1-3 are active in the metabolism of a wide variety of xenobiotics 
including drugs (Rendic and Di Carlo, 1997; Pelkonen et al. 2005; Zanger et al. 2008). CYPs 
are found in high concentration in the liver, but are present in a variety of other tissues, 
including lung, kidney, the gastrointestinal tract, nasal mucosa, skin and brain (Lawton et 
al. 1990; Hjelle et al. 1986; Tremaine et al. 1985; Dutcher and Boyd, 1979; Peters and Kremers, 
1989; Adams et al. 1991; Eriksson and Brittebo, 1991; Khan et al. 1989; Dhawan et al. 1990; 
Bergh and Strobel, 1992) and located primarily in the endoplasmic reticulum. 
Microsomes can be prepared easily from frozen liver tissue, and enzymatic activities are 
stable during prolonged storage (Beaune et al. 1986; Pearce et al. 1996; Yamazaki et al. 1997). 
Microsomes consist of vesicles of the hepatocyte endoplasmic reticulum and are prepared 
by standard differential ultracentrifugation (Pelkonen et al. 1974). Microsomes are derived 
from the endoplasmic reticulum as a result of tissue homogenization and are isolated by two 
centrifugation steps. The tissues are typically homogenized in buffer and centrifuged at 
10.000g for 20 minutes, the resulting supernatant, referred to as S9 fraction, can be used in 
studies where both microsomal and cytosolic enzymes are needed. S9 fraction is centrifuged 
at 100.000g for 60 minutes to yield the microsomal pellets and a cytosolic supernatant. The 
pellet is typically re-suspended in a volume of buffer and stored at -70º C (Figure 3) (Testa 
and Krämer, 2005).  
 
 
Fig. 3. A simplified scheme of the preparation of microsomes (Testa and Krämer, 2006). 
Testa and Krämer: The biochemistry of drug metabolism - an introduction part 1. Principals 
and overview. Chemistry & Biodiversity. 2005, 3, 1053-1101; © Wiley-VCH Verlag GmbH & 
Co. KGaA. Reproduced with permission. 
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Microsomes have many advantages including easy adaptation to higher throughput assays, 
easy preparation and use, good stability during storage, high CYP concentration and high 
rate of metabolite turnover. (Pelkonen et al. 2005; Brandon et al. 2003; Ekins et al. 1999; Ekins 
et al. 2000; Pelkonen and Raunio, 2005). 
3.2 Function 
CYP oxidation reactions involve a complex series of steps. The initial step involves the 
binding of a substrate to oxidized CYP, followed by a one-electron reduction catalyzed by 
NADPH cytochrome P450 reductase to form a reduced cytochrome-substrate complex. The 
next several steps involve interaction with molecular oxygen, the acceptance of the second 
electron from NADPH cytochrome b5 reductase, followed by subsequent release of water 
and the oxygenated product of the reaction. This reaction sequence results in the addition of 
one oxygen atom to the substrate, while the other atom is reduced to water (Parkinson, 2001; 






Fig. 4. Generalized P450 catalytic cycle (Sohl et al. 2008) (Sohl et al. J. Biol. Chem. 2008). 
4. In vitro approaches 
In vitro approaches to characterize metabolic fate for human clearance predication have 
become more frequent with the increase in the availability of human-derived materials. All 
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models have certain advantages and disadvantages, but the common advantage to these 
approaches is the reduction of the complexity of the study system. In vitro model range 
from simple to more complex systems: individual enzymes, subcellular fractions, cellular 
systems, liver slices and whole organ, respectively. However, the use of in vitro models is 
always a compromise between convenience and relevance. Different in vitro models and 
their advantages and disadvantages have been described previously (Pelkonen et al. 2005; 
Brandon et al. 2003; Pelkonen and Raunio, 2005; Pelkonen and Turpeinen, 2007).  
5. Identification of the individual CYP enzyme(s) involved in the metabolism 
of a xenobiotic 
To understand some of the factors related to xenobiotic metabolism that can influence the 
achievement of these aims, there are several important points to consider such as 
determination of the metabolic stability of the compound, identification of reactive 
metabolites, evaluation of the variation between species, identification of human CYPs and 
their isoforms involved in the activation or detoxification, evaluation of the variation 
between individuals, identification of individuals and subpopulations at increased risk and 
finally overall improvement of the process of human risk assessment. 
Basically the identification of the individual CYP enzyme(s) involved in the metabolism of a 
xenobiotic is necessary for in vitro – in vivo extrapolation and prediction if the results of the 
metabolic stability and metabolic routes in human in vitro systems indicate that CYP 
enzymes contribute significantly to the metabolism of a xenobiotic. Due to the broad 
substrate specificity of CYP enzymes, it is possible for more than one enzyme to be involved 
in the metabolism of a single compound.  
In vitro methods have been established to determine which CYP isoform(s) is (are) involved 
in the metabolism of a xenobiotic (Pelkonen et al. 2005; Pelkonen and Raunio, 2005). The 
identification could be achieved by different approaches such as cDNA-expressed enzymes, 
correlation studies, inhibition studies with CYP-selective chemical inhibitors and specific 
antibodies and inhibition of CYP enzymes. 
5.1 cDNA-expressed enzymes 
The availability of a full panel of recombinant enzymes covering the major human liver 
CYPs allows a direct approach for assaying the metabolism of a compound by incubation 
with the isolated isoforms. This can be done by following substrate consumption or product 
formation by each isoform using the same analytical methods as for human liver 
microsomes-based assays (Reponen et al. 2010). The biotransformation of a xenobiotic by a 
single CYP does not necessarily mean its participation in the reaction in vivo. The relative 
roles of individual CYPs cannot be quantitatively estimated using this approach due to the 
interindividual variation in the levels of individual active CYPs in the liver (Guengerich, 
1999; Guengerich, 1995). However, cDNA-expressed CYPs are well suited for isozyme 
identification in a high-throughput screening format (White, 2000). The relative importance 
of individual isoform to in vivo clearance is dependent upon the relative abundance of each 
isoform. When taking into account the average composition of human hepatic CYPs, an 
approximate prediction of the participation of any CYP enzyme in the whole liver activity 
can be achieved (Rodrigues, 1999; Rostami-Hodjegan and Tucker, 2007). 
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5.2 Correlation studies 
Using a bank of “phenotyped” liver microsomes, correlation analysis could be performed. 
Correlation analysis involves measuring the rate of xenobiotic metabolism by several liver 
samples from individual humans and correlating reaction rates with the level of activity of 
the individual CYP enzymes in the same microsomal samples. If there are a sufficient 
number of individual samples (at least ten), the correlation plot would give the information 
needed for the evaluation of the participating CYPs. The higher the correlation between the 
activities, the larger the probability that the respective CYP enzyme is responsible for the 
metabolism of the xenobiotic. Another approach is to correlate the levels of an individual 
CYP determined by Western blot analysis against the metabolic activity (Beaune et al. 1986; 
Brandon et al. 2003; Berthou et al. 1994; Guengerich, 1995; Jacolot et al. 1991; Wolkers et al. 
1998).  
5.3 Inhibition studies with CYP-selective chemical inhibitors and specific antibodies 
Pooled human liver microsomes or individual liver microsomal samples should be used to 
examine the effect of CYP-selective chemical inhibitors or selective inhibitory antibodies. 
Antibody inhibition involves an evaluation of the effects of inhibitory antibodies against 
selective CYP enzymes on the metabolism of a xenobiotic in human liver microsomes. 
Chemical inhibition involves an evaluation of the effects of known CYP enzyme inhibitors 
on the metabolism of a xenobiotic. Several compounds have been characterized for their 
inhibitory potency against different CYPs; for example, furafylline is perhaps the most 
potent and selective inhibitor of CYP1A2, tranylcypromine of CYP2A6, thiotepa and 
ticlopidine of CYP2B6, trimethoprim and sulfaphenazole are selective inhibitors of CYP2C8 
and CYP2C9, respectively, fluconazole may be used for CYP2C19, quinidine is a commonly 
used in vitro diagnostic inhibitor of CYP2D6 activity, pyridine and disulfiram of CYP2E1, 
and ketoconazole and itraconazole are among many potent and relatively selective 
inhibitors of CYP3A4 often used in vitro and in vivo as diagnostic inhibitors (Rendic and Di 
Carlo, 1997; Pelkonen et al. 2005; Pelkonen and Raunio, 2005; Bourrie et al. 1996; Clarke et al. 
1994; Nebert and Russell, 2002; Pelkonen et al. 2008; Schmider et al. 1995; Sesardic et al. 
1990).  
5.4 Inhibition of CYP enzymes  
Testing the inhibitory interactions of a xenobiotic on CYP-specific model activity in human 
liver microsomes in vitro provides information about the affinity of the compound for CYP 
enzymes (Pelkonen and Raunio, 2005). The type of CYP inhibition can be either irreversible 
(mechanism-based inhibition) or reversible. Irreversible inhibition requires 
biotransformation of the inhibitor, while reversible inhibition can take place directly, 
without metabolism. Reversible inhibition is the most common type of enzyme inhibition 
and can be further divided into competitive, noncompetitive, uncompetitive, and mixed-
type inhibition (Pelkonen et al. 2008). The inhibitory interactions of a xenobiotic on CYP 
enzymes can be tested by co-incubating a series of dilutions of a xenobiotic with a reaction 
mixture containing single or multiple substrates. In the single substrate assay, traditionally 
CYP interaction studies are performed using specific assays for each CYP isoform. A 
decrease in probe metabolite formation produced by inhibition is usually analyzed by LC-
UV, LC-MS or fluorometry. In the cocktail assay, several CYP-selective probes are incubated 
with human liver microsomes and analyzed by LC-MS-MS (Tolonen et al. 2007; Turpeinen 
et al. 2006; Turpeinen et al. 2005; Tolonen et al. 2005). 
www.intechopen.com
 
Metabolism of Pesticides by Human Cytochrome P450 Enzymes In Vitro – A Survey 
 
171 
6. Pesticides reported to be metabolized at least in part by certain human 
cytochrome P450 
During the recent years, a large number of papers have been published on the activities of 
human CYPs involved in the metabolism of pesticides. Human CYPs involved in 
metabolism of pesticides and related compounds were listed and updated previously 
several years ago by Hodgson 2001 & 2003 (Hodgson, 2001; 2003). Abbreviations used in the 
coming tables are listed in table 1. The updated human CYPs and their isoforms catalyzing 
pesticides biotransformation in addition to reactions detection methods are listed below in 
tables containing the primary CYP-specific information (Tables 2 to 13). Additional 
summary table contains information classified according to individual metabolic reactions 
and chemical classes of pesticides (Table 14).  
 
Chemical class  Abb. Pesticide type Abb. Detection method Abb. 
Acylalanine AcA Algicide A. Acetylcholine esterase 
inhibition 
 
AChE inh. Carbamates CA Biocide agent B. A. 
Chloroacetamide ChAc Biocide B. Electron capture detector ECD 
Chlorinated cyclodiene CCD Fungicide F. Gas chromatography GC 
Conazole CZ Herbicide H. Liquid chromatography LC 
Neonicotinoid NC Insect repellent I. R. Mass spectrometry MS 
Organochlorine OC Insecticide I. Nuclear magnetic resonance NMR 
Organophosphorus OP Molluscicide M. Photo Diode Array Detector PDA 
Organotin OT Plant growth 
regulator 
PGR.
Thin layer chromatography TLC 
Oxathiin OX Ultraviolet detector UV 
Phenyl pyrazole PP     
pyrethroid PY     
phenyl urea PU     
Triazine TA     
Triazole TriA     
      
Table 1. Abbreviations  















Lang et al. 1997 
Atrazine TA H. 
N-Deethylation 
N-Deisopropylation 
LC-UV Lang et al. 1997 
LC/PDA & 
LC-MS 
Joo et al. 2010 






Tang et al. 2002 
Carbosulfan CA I. 
N-S cleavage 
Sulfoxidation 
LC-MS Abass et al. 2010 
cis-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
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DEET  I. R. 
Aromatic methyl 
oxidation 
LC-UV Usmani et al. 2002 
Dimethoate OP I. Desulfuration 
AChE 
inhibition 
Buratti and Testai, 2007 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Fenthion OP I. Sulfoxidation LC-UV Leoni et al. 2008 
Furametpyr OX F. N-Demethylation 
TLC, NMR, 
MS 
Nagahori et al. 2000 
 
Sulprofos OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Terbuthylazine TA H. N-Deethylation LC-UV Lang et al. 1997 
Terbutryne TA H. N-Deethylation LC-UV Lang et al. 1997 
Terbutryne TA H. Sulfoxidation LC-UV Lang et al. 1997 
τ-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
ǃ-Cyfluthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
λ-Cyhalothrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 














LC-UV Lang et al. 1997 
Atrazine TA H. 
N-Deethylation 
N-Deisopropylation 
LC-UV Lang et al. 1997 
LC/PDA & 
LC-MS 
Joo et al. 2010 
Azinophos 
methyl 
OP I. Desulfuration 
AChE Inh. 
LC-UV 
Buratti et al. 2002 
Bioresmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 




LC-UV Tang et al. 2002 
Carbofuran CA I. Ring oxidation LC-UV Usmani et al. 2004a 
Carbosulfan CA I. N-S cleavage LC-MS Abass et al. 2010 








Tang et al. 2001; 
Foxenberg et al. 2007; 
Mutch and Williams, 
2006 
cis-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Cypermethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 








Mutch and Williams, 
2006; Kappers et al. 2001 
Dimethoate OP I. Desulfuration AChE Inh. Buratti and Testai, 2007 
Disulfoton OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
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Fenthion OP I. 
Desulfuration 
Sulfoxidation 
LC-UV Leoni et al. 2008 
Furametpyr OX F. N-Demethylation 
TLC, NMR 
& MS 
Nagahori et al. 2000 
Imidacloprid NC I. Nitroimine reduction TLC 
Schulz-Jander and 
Casida, 2002 
Malathion OP I. Desulfuration AChE Inh. Buratti et al. 2005 
Methiocarb OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Methoxychlor OC I. O-Demethylation TLC 
Stresser and Kupfer, 
1998 
Parathion OP I. Desulfuration 
AChE Inh., 
LC-UV 
Buratti et al. 2002 
Parathion OP I. 




Foxenberg et al. 2007; 
Mutch and Williams, 
2006; Mutch et al. 2003; 
Mutch et al. 1999; Butler 
and Murray, 1997 
Phorate OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Sulprofos OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Terbuthylazine TA H. N-Deethylation LC-UV Lang et al. 1997 
Terbutryne TA H. 
N-Deethylation 
Sulfoxidation 
LC-UV Lang et al. 1997 
τ-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
ǃ-Cyfluthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
λ-Cyhalothrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 














LC-UV Tang et al. 2002 
Carbosulfan CA I. N-S cleavage LC-MS Abass et al. 2010 
DEET  I. R. N-Deethylation LC-UV Usmani et al. 2002 
Diazinon OP I. 
Desulfuration 
Dearylation 
LC-UV Kappers et al. 2001 
Dimethoate OP I. Desulfuration AChE Inh. Buratti and Testai, 2007 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 






Table 4. Pesticides reported to be metabolized at least in part by human CYP2A6. 
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Acetachlor ChAc H. N-Dealkoxylation LC-UV Coleman et al. 2000 
Alachlor ChAc H. N-Dealkoxylation LC-UV Coleman et al. 2000 
Ametryne TA H. Sulfoxidation LC-UV Lang et al. 1997 
Atrazine TA H. N-Deisopropylation 
LC-UV Lang et al. 1997 
LC/PDA & 
LC-MS 
Joo et al. 2010 
Azinophos 
methyl 
OP I. Desulfuration 
AChE Inh. 
LC-UV 
Buratti et al. 2002 
Bioresmethrin PY I. 
Oxidative 
metabolism 
LC-MS Scollon et al. 2009 
Butachlor ChAc H. N-Dealkoxylation LC-UV Coleman et al. 2000 




LC-UV Tang et al. 2002 
Carbosulfan CA I. 
N-S cleavage 
Sulfoxidation 
LC-MS Abass et al. 2010 








Tang et al. 2001; 
Foxenberg et al. 2007; 
Mutch and Williams 
2006; Croom et al. 2010 
DEET  I. R. 
Aromatic 
methyloxidation 
LC-UV Usmani et al. 2002 








Mutch and Williams 
2006; Kappers et al. 2001 
Dimethoate OP I. Desulfuration AChE Inh. Buratti and Testai 2007 
Disulfoton OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Endosulfan-ǂ CCD I. Sulfoxidation LC-UV Casabar et al. 2006 
GC-ECD Lee et al. 2006 






Fenthion OP I. 
Desulfuration 
Sulfoxidation 
LC-UV Leoni et al. 2008 
Malathion OP I. Desulfuration AChE Inh. Buratti et al. 2005 
Metachlor ChAc H. N-Dealkoxylation LC-UV Coleman et al. 2000 
Metalaxyl AcA F. 
O-Demethylation 
Lactone formation 
LC-MS Abass et al. 2007b 
Methiocarb OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Methoxychlor OC I. O-Demethylation TLC Stresser and Kupfer 
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Buratti et al. 2002 




Foxenberg et al. 2007; 
Mutch and Williams 
2006; Mutch et al. 2003; 
Mutch et al. 1999; Butler 
and Murray 1997 
Phorate OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Profenofos OP I. 
Hydroxypropylation
Desthiopropylation 
LC-MS Abass et al. 2007a 
Terbutryne TA H. Sulfoxidation LC-UV Lang et al. 1997 
triadimefon TriA F. 
t-butyl group 
metabolism 
LC-UV Barton et al. 2006 
λ-Cyhalothrin PY I. Oxidative 
metabolism 
LC-MS Scollon et al. 2009 










Ametryne TA H. N-Deisopropylation LC-UV Lang et al. 1997 
Atrazine TA H. N-Deisopropylation 
LC/PDA 
& LC-MS 
Joo et al. 2010 
Bifenthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Bioresmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 




LC-UV Tang et al. 2002 
Carbosulfan CA I. N-S cleavage LC-MS Abass et al. 2010 




Mutch and Williams 
2006 
cis-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Cypermethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Deltamethrin PY I. Oxidative metabolism LC-MS Godin et al. 2007 




Mutch and Williams 
2006 
Dimethoate OP I. Desulfuration AChE Inh. Buratti and Testai 2007 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Esfenvalerate PY I. Oxidative metabolism LC-MS Godin et al. 2007 




Mutch and Williams 
2006; Mutch et al. 2003 
Resmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
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S-Bioallethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
τ-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
ǃ-Cyfluthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
λ-Cyhalothrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 










Ametryne TA H. 
N-Deisopropylation 
Sulfoxidation 
LC-UV Lang et al. 1997 
Atrazine TA H. N-Deisopropylation 
LC/PDA 
& LC-MS 
Joo et al. 2010 
Bifenthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Bioresmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 




LC-UV Tang et al. 2002 




Tang et al. 2001; Croom 
et al. 2010 
cis-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Cypermethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Diazinon OP I. 
Desulfuration 
Dearylation 
LC-UV Kappers et al. 2001 
Dimethoate OP I. Desulfuration AChE Inh. Buratti and Testai 2007 
Disulfoton OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Endosulfan-ǂ CCD I. Sulfoxidation LC-UV Casabar et al. 2006 
Esfenvalerate PY I. Oxidative metabolism LC-MS Godin et al. 2007 
Fenthion OP I. 
Desulfuration 
Sulfoxidation 
LC-UV Leoni et al. 2008 






Methiocarb OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Methoxychlor OC I. O-Demethylation TLC 
Stresser and Kupfer 
1998 
Parathion OP I. 
Desulfuration 
Dearylation 
LC-UV Foxenberg et al. 2007 
Phorate OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Resmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
S-Bioallethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Sulprofos OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
τ-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
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Dearylation GC Ohhira et al. 2006 
ǃ-Cyfluthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
λ-Cyhalothrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 










Ametryne TA H. 
N-Deethylation 
N-Deisopropylation 
LC-UV Lang et al. 1997 





Lang et al. 1997 
LC/PDA 
& LC-MS 
Joo et al. 2010 
Azinophos 
methyl 
OP I. Desulfuration 
AChE Inh. 
& LC-UV 
Buratti et al. 2002 
Bifenthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Bioresmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 




LC-UV Tang et al. 2002 
Carbofuran CA I. Ring oxidation LC-UV Usmani et al. 2004a 





Abass et al. 2010 








Tang et al. 2001; 
Foxenberg et al. 2007; 
Mutch and Williams 
2006; Croom et al. 2010 
cis-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Cypermethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 







Oxidative metabolism LC-MS Godin et al. 2007 








Mutch and Williams 
2006; Kappers et al. 2001 
Dimethoate OP I. Desulfuration AChE Inh. Buratti and Testai 2007 
Disulfoton OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
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Endosulfan-ǂ CCD I. Sulfoxidation LC-UV Casabar et al. 2006 
Esfenvalerate PY I. Oxidative metabolism LC-MS Godin et al. 2007 
Fenthion OP I. 
Desulfuration 
Sulfoxidation 
LC-UV Leoni et al. 2008 
Fipronil PP I. Sulfoxidation LC-UV Tang et al. 2004 
Furametpyr OX F. N-Demethylation 
TLC NMR 
& MS 
Nagahori et al. 2000 
Imidacloprid NC I. oxidation TLC 
Schulz-Jander and 
Casida 2002 
Malathion OP I. Desulfuration AChE Inh. Buratti et al. 2005 
Methiocarb OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Methoxychlor OC I. 
O-Demethylation 
bis-O-Demethylation 
TLC Stresser and Kupfer 1998 
Myclobutanil TriA F. n-butyl metabolism LC-UV Barton et al. 2006 




Foxenberg et al. 2007; 
Mutch and Williams 
2006; Mutch et al. 2003 
Parathion OP I. Desulfuration 
AChE Inh.
& LC-UV 
Buratti et al. 2002 
 
Phorate OP I. Sulfoxidation LC-UV Usmani et al. 2004b 





Abass et al. 2007a 
Resmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
S-Bioallethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Sulprofos OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Terbuthylazine TA H. N-Deethylation LC-UV Lang et al. 1997 
τ Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
triadimefon TA F. t-butyl metabolism LC-UV Barton et al. 2006 
Tributyltin OT B. A. Dealkylation GC Ohhira et al. 2006 
Triphenyltin OT 
F.; A.;  
M. 
Dearylation GC Ohhira et al. 2006 
ǃ-Cyfluthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
λ-Cyhalothrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 










Atrazine TA H. N-Deethylation LC-UV Lang et al. 1997 




LC-UV Tang et al. 2002 








Metabolism of Pesticides by Human Cytochrome P450 Enzymes In Vitro – A Survey 
 
179 
Desulfuration AChE Inh. Sams et al. 2000 
DEET  I. R. 
Aromatic methyl 
oxidation 
LC-UV Usmani et al. 2002 
Diazinon OP I. 




Mutch and Williams 
2006; Kappers et al. 2001 
Disulfoton OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Imidacloprid NC I. Nitroimine reduction TLC 
Schulz-Jander and 
Casida 2002 
Methiocarb OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Parathion OP I. Desulfuration 
LC-UV 
Mutch and Williams 
2006; Mutch et al. 2003 
AChE Inh. Sams et al. 2000 
Sulprofos OP I. Sulfoxidation LC-UV Usmani et al. 2004b 










Atrazine TA H. 
N-Deethylation 
N-Deisopropylation 




Joo et al. 2010 




LC-UV Tang et al. 2002 
DEET  I. R. 
Aromatic methyl 
oxidation 
LC-UV Usmani et al. 2002 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Imidacloprid NC I. Nitroimine reduction TLC 
Schulz-Jander and 
Casida 2002 





Mutch and Williams 
2006; Mutch et al. 2003 
 
 
Table 10. Pesticides reported to be metabolized at least in part by human CYP2E1.  
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Acetachlor ChAc H. N-Dealkoxylation LC-UV Coleman et al. 2000 





Coleman et al. 2000; 
Coleman et al. 1999 




LC-UV Lang et al. 1997 
Atrazine TA H. 
N-Deethylation 
N-Deisopropylation 
LC-UV Lang et al. 1997 
LC/PDA & 
LC-MS
Joo et al. 2010 
Azinophos 
methyl 
OP I. Desulfuration 
AChE Inh. & 
LC-UV
Buratti et al. 2002 
Bioresmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Butachlor ChAc H. N-Dealkoxylation LC-UV Coleman et al. 2000 




LC-UV Tang et al. 2002 
Carbofuran CA I. Ring oxidation LC-UV Usmani et al. 2004a 
Carbosulfan CA I. 
N-S cleavage
Sulfoxidation







AchE Inh. & 
LC-UV 
Buratti et al. 2002; Sams 





Tang et al. 2001; 
Foxenberg et al. 2007; 
Mutch and Williams 
2006; Croom et al. 2010; 
Dai et al. 2001 
cis-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Cypermethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
DEET I. R. N-Deethylation LC-UV Usmani et al. 2002 
Diazinon OP I. 
Desulfuration 
AchE Inh. & 
LC-UV 
Buratti et al. 2002 




Mutch and Williams 
2006; Kappers et al. 2001 
Dimethoate OP I. Desulfuration AChE Inh. Buratti and Testai 2007 
Diniconazole CZ F. Hydroxylation LC-MS Mazur and Kenneke 2008 
Disulfoton OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Endosulfan-ǂ 
 
CCD I. Sulfoxidation 
LC-UV Casabar et al. 2006 
GC-ECD Lee et al. 2006 
Endosulfan-ǃ CCD I. Sulfoxidation GC-ECD Lee et al. 2006 
Epoxiconazole CZ F. Hydroxylation LC-MS Mazur and Kenneke 2008 
Fenbuconazole CZ F. Hydroxylation LC-MS Mazur and Kenneke 2008 
Fenthion OP I. 
Desulfuration
Sulfoxidation 
LC-UV Leoni et al. 2008 
Desulfuration 
AChE Inh. & 
LC-UV 
Buratti et al. 2006 
Fipronil PP I. Sulfoxidation LC-UV Tang et al. 2004 
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Furametpyr OX F. N-Demethylation 
TLC NMR & 
MS






TLC NMR & 
MS
Mehmood et al. 1996 
Hexaconazole CZ F. Hydroxylation LC-MS Mazur and Kenneke 2008 







Ipconazole CZ F. Hydroxylation LC-MS Mazur and Kenneke 2008 
Malathion OP I. Desulfuration 
AChE Inh. & 
LC-UV
Buratti et al. 2005; Buratti 
et al. 2006 





LC-MS Abass et al. 2007b 
Metconazole CZ F. Hydroxylation LC-MS Mazur and Kenneke 2008 
Methiocarb OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Myclobutanil TA F. n-butyl metabolism LC-UV Barton et al. 2006 
Myclobutanil TA F. 
Aliphatic hydroxy-
lation
LC-MS Mazur and Kenneke 2008 
Paclobutrazole TA PGR Hydroxylation LC-MS Mazur and Kenneke 2008 
Parathion OP I. 
Desulfuration 
AChE Inh. & 
LC-UV
Buratti et al. 2002; Buratti 
et al. 2006 





Foxenberg et al. 2007; 
Mutch and Williams 
2006; Mutch et al. 2003; 
Mutch et al. 1999; Butler 






TLC NMR & 
MS
Mehmood et al. 1996 
Phorate OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Profenofos OP I. 
Hydroxypropylation
Desthiopropylation
LC-MS Abass et al. 2007a 
Propiconazole CZ F. 
Aliphatic hydroxy-
lation
LC-MS Mazur and Kenneke 2008 
Resmethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
S-Bioallethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Sulprofos OP I. Sulfoxidation LC-UV Usmani et al. 2004b 
Terbuthylazine TA H. N-Deethylation LC-UV Lang et al. 1997 
Terbutryne TA H. 
N-Deethylation
Sulfoxidation






LC-MS Mazur and Kenneke 2008 
τ-Permethrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
triadimefon TA F. 
t-butyl group 
metabolism
LC-UV Barton et al. 2006 




Dearylation GC Ohhira et al. 2006 
Triticonazole CZ F. Hydroxylation LC-MS Mazur and Kenneke 2008 
Uniconazole CZ PGR. Hydroxylation LC-MS Mazur and Kenneke 2008 
ǃ-Cyfluthrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
λ-Cyhalothrin PY I. Oxidative metabolism LC-MS Scollon et al. 2009 
Table 11. Pesticides reported to be metabolized at least in part by human CYP3A4.  
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LC-UV Tang et al. 2002 
Carbosulfan CA I. 
N-S cleavage 
Sulfoxidation 
LC-MS Abass et al. 2010 





Foxenberg et al. 2007; 
Mutch and Williams 
2006; Croom et al. 2010 
Desulfuration 
AChE Inh. & 
LC-UV 
Buratti et al. 2006 
DEET  I. R. N-Deethylation LC-UV Usmani et al. 2002 
Deltamethrin PY I. Oxidative metabolism LC-MS Godin et al. 2007 
Diazinon OP I. 
Desulfuration 
Dearylation 
LC-UV Mutch and Williams 2006 
Diuron PU H. N-Demethylation LC-MS Abass et al. 2007c 
Endosulfan-ǂ CCD I. Sulfoxidation GC-ECD Lee et al. 2006 
Endosulfan-ǃ CCD I. Sulfoxidation GC-ECD Lee et al. 2006 
Esfenvalerate PY I. Oxidative metabolism LC-MS Godin et al. 2007 
Fenthion OP I. Desulfuration 
AChE Inh. & 
LC-UV 
Buratti et al. 2006 
Malathion OP I. Desulfuration 
AChE Inh. & 
LC-UV 
Buratti et al. 2006 
Myclobutanil TriA F. n-butyl metabolism LC-UV Barton et al. 2006 





Foxenberg et al. 2007; 
Mutch and Williams 
2006; Mutch et al. 2003; 
Mutch et al. 1999 
Desulfuration 
AChE Inh. & 
LC-UV 
Buratti et al. 2006 







Table 12. Pesticides reported to be metabolized at least in part by human CYP3A5.  
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Atrazine TA H. N-Deisopropylation
LC/PDA & 
LC-MS 
Joo et al. 2010 
Carbosulfan CA I. 
N-S cleavage 
Sulfoxidation 
LC-MS Abass et al. 2010 




Foxenberg et al. 





Buratti et al. 2006 
Endosulfan-
ǂ CCD I. Sulfoxidation LC-UV Casabar et al. 2006 
Fenthion OP I. Desulfuration 
AChE Inh. 
& LC-UV 
Buratti et al. 2006 
Malathion OP I. Desulfuration 
AChE Inh. 
& LC-UV 
Buratti et al. 2006 









Buratti et al. 2006 
Table 13. Pesticides reported to be metabolized at least in part by human CYP3A7. 
6.13 Metabolic reactions  
Table 14 contains information classified according to individual metabolic reactions and the 
corresponding pesticides. 
 














bis-O-Demethylation Methoxychlor CYP2C18 
Dealkylation Tributyltin CYP2C9; CYP2C18; CYP2C19; CYP3A4 
Dearylation  
Chlorpyrifos; diazinon 
CYP1A2; CYP2A6; CYP2B6;CYP2C9; 
CYP2C19; CYP2D6; CYP3A4; CYP3A5 
 
Parathion 
CYP2C19; CYP3A4; CYP2B6; CYP2C8; 
CYP3A5; CYP1A2;  
Triphenyltin CYP2C9; CYP2C18; CYP2C19; CYP3A4 
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Desthiopropylation Profenofos CYP3A4; CYP2B6 
Desulfuration 
Azinophos methyl CYP2C19; CYP3A4 
Chlorpyrifos 
CYP2C19; CYP3A4; CYP2B6; CYP3A5; 
CYP2D6; CYP3A7 
Diazinon 
CYP1A2; CYP2A6; CYP2B6;CYP2C9; 
CYP2C19; CYP2D6; CYP3A4; CYP3A5 
Dimethoate CYP1A2; CYP3A4 
Fenthion; malathion 
CYP1A2; CYP2B6; CYP3A4; CYP3A5; 
CYP3A7 
Parathion 
CYP2C19; CYP3A4; CYP2B6; CYP2C8; 












Lactone formation Metalaxyl CYP2B6 












CYP1A1 CYP1A2 CYP2C19 CYP3A4 
DEET CYP2C19 
N-Deisopropylation Ametryne; atrazine 
CYP1A1; CYP1A2CYP2B6 CYP2E1 CYP2C8 
CYP2C9 CYP2C19 CYP3A4, CYP3A7 
N-Demethylation 
Diuron CYP1A1; CYP1A2; CYP2C19; CYP3A4 
Furametpyr CYP1A2; CYP2C19 
Nitroimine reduction Imidacloprid CYP3A4 
N-S cleavage Carbosulfan CYP3A4; CYP3A5 
O-Demethylation 
Metalaxyl CYP2B6 






τ -permethrin CYP1A2; CYP2C19 
cis-permethrin; resmethrin CYP2C9; CYP2C19 
Deltamethrin CYP2C8; CYP2C19; CYP3A5 
Esfenvalerate CYP2C8; CYP2C19; CYP3A5; CYP2C9 
τ-cyfluthrin CYP2C8; CYP2C19 
Ring hydroxylation Metalaxyl CYP3A4 
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Ring oxidation Carbofuran CYP3A4 
Sulfoxidation 
Ametryn CYP1A2 
Carbosulfan CYP1A1; CYP2B6; CYP3A5 
Disulfoton; phorate; sulprofos CYP2C9; CYP2C18; CYP2C19 
Endosulfan-ǂ CYP2B6; CYP3A4 
Endosulfan-ǃ CYP3A4; CYP3A5 
Fenthion; methiocarb CYP2C9; CYP2C19 
Fipronil CYP3A4 




Table 14. Type of reactions catalyzed at least in part by CYPs  in one or more corresponding 
pesticide biotransformation. 
7. Induction of CYP enzymes 
Induction is defined as an increase in enzyme activity associated with an increase in 
intracellular enzyme concentration. CYP-pesticides interactions involve either induction or 
inhibition of metabolizing enzymes. Many induction studies have been conducted in vitro 
using primary human hepatocytes, human hepatoma cell lines or cell lines derived from 
other human tissues (Dierickx, 1999; Delescluse et al. 2001; Coumoul et al. 2002; Sanderson 
et al. 2002; Wyde et al. 2003; Lemaire et al. 2004). Primary culture of hepatocyte maintain 
whole cell metabolism since transporters and both phase I and phase II enzymes are present. 
Likewise, HepaRG cells express a large panel of liver-specific genes including several CYP 
enzymes, which is in contrast to HepG2 cell lines. In addition to P450 enzymes, HepaRG 
cells have a stable expression of phase II enzymes, transporters and nuclear transcription 
factors over a time period of six weeks in culture (Aninat et al. 2006; Anthérieu et al. 2010; 
Kanebratt and Andersson, 2008; Turpeinen et al. 2009). 
Both immunoblotting and reverse transcription polymerase chain reaction (RT-PCR) 
techniques have been applied to examine the pesticide-CYP induction (Wyde et al. 2003; 
Lemaire et al. 2004; Das et al. 2006; Sun et al. 2005; Johri et al. 2007; Barber et al. 2007). 
However, problems in tissue availability, interindividual differences, reproducibility and 
ethical issues preclude the efficient large-scale use of human primary hepatocytes for 
induction screening.  
One important factor regulating the expression of drug metabolising enzymes is induction 
by a diverse group of endogenous and exogenous substances that bind to the nuclear 
receptors pregnane X  receptor (PXR) or constitutive androstane receptor (CAR), thereby 
causing significant up-regulation of gene transcription (Pelkonen et al. 2008; Handschin and 
Meyer, 2003). Therefore, the development of mechanism-based test systems for induction 
screening, based for example on in vitro pregnane X receptor/constitutive androstane 
receptor activation, is currently very active, and some test systems are in use as a first step 
for the identification of potential inducers (Pelkonen et al. 2005; Pelkonen and Raunio, 2005). 
Whereas the acute effects of exposure to high doses of pesticides are well known, the long-
term effects of lower exposure levels remain controversial. The ability of chemicals to induce 
metabolic enzymes, including cytochrome P450 (CYP), has long been considered as one of 
www.intechopen.com
 
Insecticides – Advances in Integrated Pest Management 
 
186 
the most sensitive biochemical cellular responses to toxic insult (Gonzalez et al. 1993; 
Denison and Whitlock Jr., 1995), since it often occurs at much lower doses of the chemical 
than those known to cause lethal or overtly toxic effects. Assessment of inducibility of 
xenobiotic-metabolising enzymes by pesticides is vital for health risk assessment. Numerous 
pesticides are capable of inducing their own metabolism and by enzyme induction can also 
lead to enhanced biotransformation of other xenobiotics. Several articles on CYP gene 
inducibility by pesticides and other chemicals used in agriculture and public health have 
been published (Abass et al. 2009) and a review article dealing with CYP gene modulation 
by pesticides is needed.   
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